OBJECTIVE: Previously we showed that, in mice, peripheral administration of glucagon-like peptide 2 (GLP-2) or [Gly2]GLP-2, the degradation-resistant analogue of GLP-2, reduces food intake in the short term. The purposes of the present study were to compare the influence of [Gly2]GLP-2 with the anorectic effect induced by glucagon-like peptide 1 (GLP-1) and to analyze the mechanism of action responsible for GLP-2-induced effects. METHODS: Food intake was measured in mice, fasted for 16-18 h, at the first hour following peptide or vehicle intraperitoneally (i.p.) administration. The effects of GLP-2 (3-33), GLP-2 receptor (GLP-2R) antagonist, and exendin (9-39), GLP-1R antagonist were also evaluated. To analyze the mechanism of action the effects of [Gly2]GLP-2 on gastric emptying were determined, and its influence on the food intake was examined in mice with sensory deafferentation induced by capsaicin pretreatment. RESULTS: Administration of [Gly2]GLP-2 (0.60 µg/g b.w.) caused a significant reduction in the food intake when compared with vehicle treated mice, which was blocked by the GLP-2 receptor antagonist, GLP-2 (3-33), or by the GLP-1 receptor antagonist, exendin (9-39). Both antagonists per se did not alter food intake. Also GLP-1 (0.30 µg/g b.w.) significantly inhibited food intake and the dose that inhibited the food intake by 50%, was lower than that determined for [Gly2]GLP-2. The effect was antagonized by the GLP-1 receptor antagonist, but not by the GLP-2 receptor antagonist. Coadministration of [Gly2]GLP-2 and GLP-1 did not cause any additive inhibition on the food intake. The rate of gastric emptying was significant decreased in [Gly2]GLP-2 treated animals compared with vehicle treated mice. Sensory deafferentation by capsaicin blocked the effects of [Gly2]GLP-2 peripheral injection, while it did not alter food intake in vehicle treated mice. CONCLUSIONS: Our results suggest that [Gly2]GLP-2 is less potent than GLP-1 in inducing inhibition of the food intake in mice. GLP-1 and GLP-2 appear to act through a common pathway. GLP-2 exerts its effect through peripheral neural mechanisms and requires the functional activity of GLP-1R signaling.

Baldassano, S., Bellanca, A., Serio, R., Mulè, F. (2012). Peripheral Glucagon-like peptide 2 administration inhibits food intake in mice: Analysis of the mechanism of action.. In Neurogastroenterol. Mot., 2012, 24 (suppl. 2), 54..

Peripheral Glucagon-like peptide 2 administration inhibits food intake in mice: Analysis of the mechanism of action.

BALDASSANO, Sara;SERIO, Rosa Maria;MULE', Flavia
2012-01-01

Abstract

OBJECTIVE: Previously we showed that, in mice, peripheral administration of glucagon-like peptide 2 (GLP-2) or [Gly2]GLP-2, the degradation-resistant analogue of GLP-2, reduces food intake in the short term. The purposes of the present study were to compare the influence of [Gly2]GLP-2 with the anorectic effect induced by glucagon-like peptide 1 (GLP-1) and to analyze the mechanism of action responsible for GLP-2-induced effects. METHODS: Food intake was measured in mice, fasted for 16-18 h, at the first hour following peptide or vehicle intraperitoneally (i.p.) administration. The effects of GLP-2 (3-33), GLP-2 receptor (GLP-2R) antagonist, and exendin (9-39), GLP-1R antagonist were also evaluated. To analyze the mechanism of action the effects of [Gly2]GLP-2 on gastric emptying were determined, and its influence on the food intake was examined in mice with sensory deafferentation induced by capsaicin pretreatment. RESULTS: Administration of [Gly2]GLP-2 (0.60 µg/g b.w.) caused a significant reduction in the food intake when compared with vehicle treated mice, which was blocked by the GLP-2 receptor antagonist, GLP-2 (3-33), or by the GLP-1 receptor antagonist, exendin (9-39). Both antagonists per se did not alter food intake. Also GLP-1 (0.30 µg/g b.w.) significantly inhibited food intake and the dose that inhibited the food intake by 50%, was lower than that determined for [Gly2]GLP-2. The effect was antagonized by the GLP-1 receptor antagonist, but not by the GLP-2 receptor antagonist. Coadministration of [Gly2]GLP-2 and GLP-1 did not cause any additive inhibition on the food intake. The rate of gastric emptying was significant decreased in [Gly2]GLP-2 treated animals compared with vehicle treated mice. Sensory deafferentation by capsaicin blocked the effects of [Gly2]GLP-2 peripheral injection, while it did not alter food intake in vehicle treated mice. CONCLUSIONS: Our results suggest that [Gly2]GLP-2 is less potent than GLP-1 in inducing inhibition of the food intake in mice. GLP-1 and GLP-2 appear to act through a common pathway. GLP-2 exerts its effect through peripheral neural mechanisms and requires the functional activity of GLP-1R signaling.
Neurogastroenterology & Motility Joint International meeting
Bologna, Italy
September 6 – 8, 2012
2012
1
Baldassano, S., Bellanca, A., Serio, R., Mulè, F. (2012). Peripheral Glucagon-like peptide 2 administration inhibits food intake in mice: Analysis of the mechanism of action.. In Neurogastroenterol. Mot., 2012, 24 (suppl. 2), 54..
Proceedings (atti dei congressi)
Baldassano, S; Bellanca, A; Serio, R; Mulè, F
File in questo prodotto:
File Dimensione Formato  
j.1365-2982.2012.01997.x.pdf

accesso aperto

Dimensione 4.34 MB
Formato Adobe PDF
4.34 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/75298
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact